Inspire Investing’s Ascendis Pharma A/S ASND Stock Holding History

Inspire Investing’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.38M	Buy	+10,428	New	+$2.64M	0.1%	258

Other funds holding ASND

Braun Stacey Associates New York $3.48B AUM 48.73% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

Henry James International Management New York $330M AUM 35.5% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

Diversify Advisory Services Sandy, Utah $6.69B AUM 18.85% 1-Year Est. Return

Diversify Wealth Management Sandy, Utah $6.69B AUM 22.4% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Sigma Planning Corp Ann Arbor, Michigan $3.88B AUM 23.38% 1-Year Est. Return

Inspire Investing's ASND Position: Q3 2026 in Review

Inspire Investing opened a new position in Ascendis Pharma A/S (ASND) in Q3 2026: 10,428 shares worth $2.38M. The stake represents 0.1% of the portfolio and ranks #258 among its holdings.

62 funds tracked by Wall St. Rank hold ASND as of Q3 2026.

Inspire Investing held 10,428 shares of Ascendis Pharma A/S worth $2.38M as of Q3 2026.
Ascendis Pharma A/S was a new Inspire Investing position in Q3 2026.
Ascendis Pharma A/S made up 0.1% of Inspire Investing's portfolio in Q3 2026, its #258 holding.
62 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2026.

Based on Inspire Investing's 13F filing for Q3 2026, filed 22 Oct 2026.